JPWO2022101633A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022101633A5 JPWO2022101633A5 JP2023528449A JP2023528449A JPWO2022101633A5 JP WO2022101633 A5 JPWO2022101633 A5 JP WO2022101633A5 JP 2023528449 A JP2023528449 A JP 2023528449A JP 2023528449 A JP2023528449 A JP 2023528449A JP WO2022101633 A5 JPWO2022101633 A5 JP WO2022101633A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- referred
- acceptable salt
- peptide ligand
- pharma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2017927.1 | 2020-11-13 | ||
| GBGB2017927.1A GB202017927D0 (en) | 2020-11-13 | 2020-11-13 | Bicyclic peptide ligands specific for transferrin |
| GB2106903.4 | 2021-05-14 | ||
| GBGB2106903.4A GB202106903D0 (en) | 2021-05-14 | 2021-05-14 | Bicycle peptide ligands specific for transferrin |
| US202163261820P | 2021-09-29 | 2021-09-29 | |
| US63/261,820 | 2021-09-29 | ||
| PCT/GB2021/052927 WO2022101633A1 (en) | 2020-11-13 | 2021-11-12 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1) |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023549229A JP2023549229A (ja) | 2023-11-22 |
| JP2023549229A5 JP2023549229A5 (https=) | 2024-11-21 |
| JPWO2022101633A5 true JPWO2022101633A5 (https=) | 2024-11-21 |
| JP7848202B2 JP7848202B2 (ja) | 2026-04-20 |
Family
ID=81600834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023528449A Active JP7848202B2 (ja) | 2020-11-13 | 2021-11-12 | トランスフェリン受容体１（ＴｆＲ１）に特異的な二環式ペプチドリガンド |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11970555B2 (https=) |
| EP (1) | EP4244235A1 (https=) |
| JP (1) | JP7848202B2 (https=) |
| KR (1) | KR20230107589A (https=) |
| CN (1) | CN116802190A (https=) |
| AR (1) | AR126029A1 (https=) |
| AU (1) | AU2021376917A1 (https=) |
| CA (1) | CA3201414A1 (https=) |
| IL (1) | IL302713A (https=) |
| MX (1) | MX2023005624A (https=) |
| SA (1) | SA523440745B1 (https=) |
| WO (1) | WO2022101633A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL302713A (en) | 2020-11-13 | 2023-07-01 | Bicycletx Ltd | Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1) |
| GB202206431D0 (en) * | 2022-05-03 | 2022-06-15 | Bicycletx Ltd | Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1) |
| KR20260021596A (ko) * | 2023-04-05 | 2026-02-13 | 아이오니스 파마수티컬즈, 인코포레이티드 | Pln 발현을 감소시키는 화합물 및 방법 |
| WO2025073871A1 (en) | 2023-10-03 | 2025-04-10 | Bicycletx Limited | Bicyclic peptide ligand complexes specific for tfr1 |
| GB202316970D0 (en) * | 2023-11-06 | 2023-12-20 | Bicycletx Ltd | Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009211253B2 (en) | 2008-02-05 | 2014-11-06 | Bicyclerd Limited | Methods and compositions |
| GB0914110D0 (en) * | 2009-08-12 | 2009-09-16 | Medical Res Council | Peptide libraries |
| WO2016077840A2 (en) * | 2014-11-14 | 2016-05-19 | Ossianix, Inc. | TfR SELECTIVE BINDING COMPOUNDS AND RELATED METHODS |
| CN104650186A (zh) | 2015-03-09 | 2015-05-27 | 中国药科大学 | 一种能够与TfR1特异性结合的活性肽及其应用 |
| GB201706477D0 (en) * | 2017-04-24 | 2017-06-07 | Bicycle Therapeutics Ltd | Modification of polypeptides |
| WO2018197893A1 (en) | 2017-04-27 | 2018-11-01 | Bicycletx Limited | Bicyclic peptide ligands and uses thereof |
| CN111183147B (zh) * | 2017-08-04 | 2024-07-05 | 拜斯科技术开发有限公司 | Cd137特异性的双环肽配体 |
| CA3080351A1 (en) * | 2017-11-02 | 2019-05-09 | Ossianix, Inc. | Improved tfr-selective binding peptides capable of crossing the blood brain barrier |
| JP2021514953A (ja) * | 2018-02-23 | 2021-06-17 | バイスクルテクス・リミテッド | 多量体二環式ペプチドリガンド |
| WO2020084305A1 (en) * | 2018-10-23 | 2020-04-30 | Bicycletx Limited | Bicyclic peptide ligands and uses thereof |
| JP2022514618A (ja) * | 2018-12-21 | 2022-02-14 | バイスクルテクス・リミテッド | Ｐｄ－ｌ１に特異的な二環式ペプチドリガンド |
| GB201912320D0 (en) * | 2019-08-28 | 2019-10-09 | Bicycletx Ltd | PBP Binding Bicyclic Peptide Ligands |
| IL302713A (en) | 2020-11-13 | 2023-07-01 | Bicycletx Ltd | Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1) |
-
2021
- 2021-11-12 IL IL302713A patent/IL302713A/en unknown
- 2021-11-12 US US17/454,665 patent/US11970555B2/en active Active
- 2021-11-12 KR KR1020237017137A patent/KR20230107589A/ko active Pending
- 2021-11-12 AR ARP210103150A patent/AR126029A1/es unknown
- 2021-11-12 JP JP2023528449A patent/JP7848202B2/ja active Active
- 2021-11-12 WO PCT/GB2021/052927 patent/WO2022101633A1/en not_active Ceased
- 2021-11-12 CA CA3201414A patent/CA3201414A1/en active Pending
- 2021-11-12 AU AU2021376917A patent/AU2021376917A1/en active Pending
- 2021-11-12 EP EP21819173.2A patent/EP4244235A1/en active Pending
- 2021-11-12 CN CN202180089518.5A patent/CN116802190A/zh active Pending
- 2021-11-12 MX MX2023005624A patent/MX2023005624A/es unknown
-
2023
- 2023-05-11 SA SA523440745A patent/SA523440745B1/ar unknown
-
2024
- 2024-03-19 US US18/610,009 patent/US20240391959A1/en not_active Abandoned
-
2025
- 2025-04-23 US US19/187,619 patent/US20250340595A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021203223A1 (en) | Stabilized anti-microbial peptides | |
| ES2544573T3 (es) | Inhibidores diméricos de afinidad elevada de PSD-95 y su uso para el tratamiento del daño cerebral isquémico y del dolor | |
| KR101413051B1 (ko) | 뉴로펩타이드 ｙ 수용체 결합성 화합물을 포함하는 세포독성 접합체 | |
| JPWO2021019243A5 (https=) | ||
| EP2717902B1 (en) | Use of modified vasoactive intestinal peptides in the treatment of hypertension | |
| TW202317604A (zh) | 用於治療遺傳性血鐵沉積症之鐵調素模擬物 | |
| CN110114065A (zh) | 通过甲状旁腺激素受体刺激进行的骨折靶向性骨再生 | |
| CN105934257A (zh) | 用于含氮和羟基的药物的生物可逆引入基团 | |
| JP2022090049A (ja) | Ｎｐｒａアゴニスト、組成物およびその使用 | |
| PE20231506A1 (es) | Peptidos y combinaciones de peptidos para su uso en inmunoterapia contra una infeccion por sars-cov-2 (covid-19) | |
| JPWO2020120984A5 (https=) | ||
| CN110248953A (zh) | 新型订书肽及其用途 | |
| JP7809117B2 (ja) | Ｇｌｐ－１／ｇｌｐ－２デュアルアゴニストの医薬組成物 | |
| JP7751641B2 (ja) | Ｇｌｐ－１／ｇｌｐ－２デュアルアゴニストの医薬組成物 | |
| JPWO2020120983A5 (https=) | ||
| WO2017048812A1 (en) | Skin-penetrating peptides and compositions and methods of use thereof | |
| US20200062811A1 (en) | Yap protein inhibiting polypeptide and application thereof | |
| JPWO2020120981A5 (https=) | ||
| ES2607986T3 (es) | Agentes terapéuticos para regular el fósforo en suero | |
| US20170319648A1 (en) | High activity tumour inhibitor and preparation method and use thereof | |
| JPWO2022101633A5 (https=) | ||
| CN115636868B (zh) | 一种基于阳离子纳米载体的多肽递送系统及其制备方法和用途 | |
| JP2019511567A5 (https=) | ||
| JPH04500363A (ja) | 心房ペプチド誘導体 | |
| CN117120459A (zh) | 抗感染双环肽配体 |